Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta …

A Tran, SM Fernando, B Rochwerg… - The Lancet …, 2023 - thelancet.com
Background Venovenous extracorporeal membrane oxygenation (ECMO) can be
considered for patients with COVID-19-associated acute respiratory distress syndrome …

[HTML][HTML] Different methods to improve the monitoring of noninvasive respiratory support of patients with severe pneumonia/ARDS due to COVID-19: an update

P Pelosi, R Tonelli, C Torregiani, E Baratella… - Journal of Clinical …, 2022 - mdpi.com
The latest guidelines for the hospital care of patients affected by coronavirus disease 2019
(COVID-19)-related acute respiratory failure have moved towards the widely accepted use of …

[HTML][HTML] In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre …

R Lorusso, ME De Piero, S Mariani… - The Lancet …, 2023 - thelancet.com
Background Extracorporeal membrane oxygenation (ECMO) has been widely used in
patients with COVID-19, but uncertainty remains about the determinants of in-hospital …

[HTML][HTML] Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis

RR Ling, K Ramanathan, JJL Sim, SN Wong, Y Chen… - Critical care, 2022 - Springer
Background Extracorporeal membrane oxygenation (ECMO) has been used extensively for
coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) …

Complications Associated With Venovenous Extracorporeal Membrane Oxygenation—What Can Go Wrong?

R Teijeiro-Paradis, WD Gannon, E Fan - Critical Care Medicine, 2022 - journals.lww.com
OBJECTIVES: Despite increasing use and promising outcomes, venovenous extracorporeal
membrane oxygenation (VV ECMO) introduces the risk of a number of complications across …

Extracorporeal membrane oxygenation during the first three waves of the coronavirus disease 2019 pandemic: A retrospective single‐center registry study

E Widmeier, T Wengenmayer, S Maier, C Benk… - Artificial …, 2022 - Wiley Online Library
Background Despite increasing knowledge about the optimal treatment for patients with
severe COVID‐19, data from different cohorts suggested that survival of patients treated with …

[HTML][HTML] Early vvECMO implantation may be associated with lower mortality in ARDS

P Rosenberger, L Korell, HA Haeberle, V Mirakaj… - Respiratory …, 2023 - Springer
Background Venovenous extracorporeal membrane oxygenation (vvECMO) is used to treat
hypoxia in patients with severe acute respiratory distress syndrome (ARDS). Nevertheless …

Airway pressure release ventilation for acute respiratory failure due to coronavirus disease 2019: A systematic review and meta-analysis

A Roshdy, AS Elsayed… - Journal of Intensive Care …, 2023 - journals.sagepub.com
Objective: To explore the evidence surrounding the use of Airway Pressure Release
Ventilation (APRV) in patients with coronavirus disease 2019 (COVID-19). Methods: A …

[HTML][HTML] Potential for recovery after extremely prolonged VV-ECMO support in well-selected severe COVID-19 patients: a retrospective cohort study

JM de Walque, C de Terwangne, R Jungers… - BMC Pulmonary …, 2024 - Springer
Abstract Background VenoVenous ExtraCorporeal Membrane Oxygenation (VV-ECMO) has
been widely used as supportive therapy for severe respiratory failure related to Acute …

[HTML][HTML] Extracorporeal membrane oxygenation for COVID-19: a systematic review

RS Aljishi, AH Alkuaibi, FA Al Zayer, AH Al Matouq - Cureus, 2022 - ncbi.nlm.nih.gov
COVID-19 may result in acute respiratory distress (ARDS) in patients with the severe form of
the disease. Extracorporeal membrane oxygenation (ECMO) can support respiratory gas …